Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Vonoprazan versus Proton Pump Inhibitors for Helicobacter pylori
IRCT20260226068950N1Phase 3Recruiting
- Sponsor
- Urmia University of Medical Sciences
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of vonoprazan in Helicobacter pylori infection, sponsored by Urmia University of Medical Sciences. Started Apr 2026; status: recruiting.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20260226068950N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260226068950N1.